Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06293482 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

A NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral, sponsored by Cochlear.

Active
Registry status
NA
Development phase
50
Enrollment target
9
Study locations

NCT06293482: Active NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral, sponsored by Cochlear.

NCT06293482 is a NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral that is active but no longer recruiting, run by Cochlear. The registered enrollment target is 50 participants, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06293482, a NA study of Hearing Loss, Sensorineural and Hearing Loss, Bilateral, is active but no longer recruiting, sponsored by Cochlear.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
9
Study locations

Study Summary

This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessments and questionnaires over the course of seven visits.

Primary Outcome

Events will be summarized by type, frequency, and severity.

Conditions Studied

Hearing Loss, Sensorineural Hearing Loss, Bilateral

Interventions

  • DEVICE Cochlear™ Nucleus® System

Study Locations (9)

Arizona

  • Barrow Neurological Institute - Phoenix
  • Centre for Neurosciences - Tucson

California

  • Pacific Neuroscience Institute - Santa Monica

Florida

  • University of Miami - Coral Gables

Indiana

  • Indiana University - Indianapolis

Missouri

  • Midwest Ear Institute - Kansas City

New York

  • New York University - New York

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • University of Pennsylvania Hospitals - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-17
Est. Completion 2028-10
Phase NA
Cochlear

34 total trials

What the registry record for NCT06293482 still lists

NCT06293482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Cochlear™ Nucleus® System is the first listed.

NCT06293482 lists 9 locations in 8 states (Arizona, California, Florida).

Frequently Asked Questions

What is clinical trial NCT06293482 about?

NCT06293482 is a clinical study titled "Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population". This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. Following cochlear implantation, participants will complete speech perception assessment...

What is the current status of trial NCT06293482?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-17. Estimated completion is 2028-10.

What conditions does trial NCT06293482 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Hearing Loss, Bilateral.

What interventions are being tested in trial NCT06293482?

The interventions under investigation include: Cochlear™ Nucleus® System (DEVICE).

Who is sponsoring clinical trial NCT06293482?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06293482 being conducted?

This trial has 9 study locations across Arizona, California, Florida, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06293482's enrollment target sits among peer trials

50 9th of 20 higher than 9 of 20 other Hearing Loss, Sensorineural trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06293482, the US trial registry maintained by the National Library of Medicine. NCT06293482 (small enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.